Disc Medicine Inc. Market Cap ($2.69 Billion)
Market Cap & Net Worth: Disc Medicine Inc. (IRON)
Disc Medicine Inc. market cap. Disc Medicine Inc. (NASDAQ:IRON) has a market capitalization of $2.69 Billion ($2.69 Billion) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #5023 globally and #1723 in its home market, demonstrating a 7.74% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Disc Medicine Inc.'s stock price $80.84 by its total outstanding shares 38392844 (38.39 Million). Also see IRON operating cash flow for how efficiently the company converts equity into cash flow.
Disc Medicine Inc. Market Cap History (2020–2026)
Disc Medicine Inc. market cap history from 2020 to 2026. Data shows change from $12.67 Billion to $3.10 Billion (-19.39% CAGR). Check latest Disc Medicine Inc. stock price today for real-time trading data and today's change.
Index Memberships
Disc Medicine Inc. is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.10% | #136 of 976 |
|
NASDAQ Composite
IXIC
|
$40.09 Trillion | 0.01% | #582 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.84 Trillion | 0.15% | #86 of 263 |
Weight: Disc Medicine Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Disc Medicine Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Disc Medicine Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Disc Medicine Inc. net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of IRON by Market Capitalization
Companies near Disc Medicine Inc. in the global market cap rankings as of November 1, 2026. Also see Disc Medicine Inc. assets under control for a full breakdown of the balance sheet.
Key companies related to Disc Medicine Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Disc Medicine Inc. (2020–2026)
Market capitalization of Disc Medicine Inc. from 2020 to today. Between 2020 and today, Disc Medicine Inc.'s market cap moved from $12.67 Billion to $ 3.10 Billion, with a yearly change of -19.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.10 Billion | +1.80% |
| 2025 | $3.05 Billion | +26.87% |
| 2024 | $2.40 Billion | +8.36% |
| 2023 | $2.22 Billion | +190.40% |
| 2022 | $763.63 Million | -77.22% |
| 2021 | $3.35 Billion | -73.55% |
| 2020 | $12.67 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Disc Medicine Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.69 Billion USD |
| MoneyControl | $2.69 Billion USD |
| MarketWatch | $2.69 Billion USD |
| marketcap.company | $2.69 Billion USD |
| Reuters | $2.69 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Disc Medicine Inc.
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associ… Read more